MTS Health Investors, LLC, a New-York based healthcare private equity firm, made an equity investment in Ovagen Fertility, a Los Angeles, California-based platform of assistive reproductive technology laboratories.
Ovagen works in four states performing all aspects of treatment and testing for infertility patients, including laboratory and genetic services as part of the in-vitro fertilization (IVF) process. Its laboratories affiliate with physician fertility clinics across the US to provide patient care in reproductive medicine.
MTS partnered with the physician owners and the company’s management team to provide capital to support future growth and advances in technology. Two of the founding physician partners, Dr. Kaylen Silverberg and Dr. George Hill, will serve as members of Ovagen’s Board of Directors.
The terms of the transaction were not disclosed.
Ovagen’s senior management team will be led by co-founder Nate Snyder, who will serve as Chief Executive Officer.